Johnson & Johnson: Drug clears more psoriasis than rival's

TRENTON, N.J. (AP) ” A study funded by drugmaker Johnson & Johnson indicates its experimental psoriasis medicine works better than a rival drug that dominates the market for biologic drugs for immune disorders.The J&J drug, guselkumab,…